01/04/2014

Zensun Announces Successful End of Phase 2 Meeting for Neucardin™ SHANGHAI, CHINA and SAN DIEGO, USA, January 4, 2014 – Zensun (Shanghai) Sci. & Tech., Ltd, and its subsidiary Zensun USA, Inc. are...

06/20/2013

Zensun Announces Positive Results for Neucardin™ to Improve Heart Func...

02/21/2013

Zensun Obtained the Exciting Results of US Phase II Clinical Trial

05/21/2012

Phase II Clinical Trial of rhNRG-1 is Near Completion

01/13/2012

Zensun has Submitted NDA of rhNRG-1 to SFDA

01/13/2012

Anti-Heart Failure Drug -- rhNRG-1 has Completed Chinese Phase II Clini...

01/11/2011

Zensun Sucessfully Finished New Round of Financing

03/30/2010

The Survival Study of rhNRG-1 Obtained Satisfying Results